Dr. Anindya Goswami
Scientist
Cancer Pharmacology
Council of Scientific and Industrial Research (CSIR)
India
Biography
He is a Principal Scientist at the CSIR(Council of Scientific & Industrial Research)-Indian Institute of Integrative Medicine, India.
Research Interest
Bioactive natural products, especially from plant origin are assigned prior thrusting areas for development of anti-tumor/anti-metastatic lead molecules.
Publications
-
Rasool, R.U.; Rah, B.; Amin, H.; Nayak, D.; Chakraborty, S.; Rawoof, A.; Mintoo, M.J.; Yousuf, K.; Mukherjee, D.; Kumar, L.D.; Mondhe, D.M.; Goswami, A. c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E. Scientific Reports (2016), DOI: 10.1038/srep18800.
-
Rasool, R.; Nayak, D.; Chakraborty, S.; Fayeem, M.; Rah, B.; Mahajan, P.; Gopinath, V.; Katoch, A.; Iqra, Z.; Yousf, S.K.; Mukherjee, D.; Kumar,L.D.; Nargotra, A.; Goswami, A. AKT is indispensable for coordinating Par-4/JNK cross talk in p21 downmodulation during ER stress. Oncogenesis, (2017), DOI: 10.1038/oncsis.2017.41.
-
Nayak, D.; Chakraborty, S.; Rasool, R.; Amin, H.; Mahajan,V.; Zilla, M.K.; Gopinath,V.; Rah, B.; Gandhi, S.G.; Ali, A.; Kumar, L.D.; Goswami, A. Inhibition of Twist1 mediated invasion by Chk2 promotes premature senescence in p53 defective cancer cells. Cell Death and Differentiation, (2017), DOI: 10.1038/cdd.2017.70.
